Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas

Joshua D. Schiffman, J. Graeme Hodgson, Scott R. Vandenberg, Patrick Flaherty, Mei Yin C Polley, Mamie Yu, Paul G. Fisher, David H. Rowitch, James M. Ford, Mitchel S. Berger, Hanlee Ji, David H. Gutmann, C. David James

Research output: Contribution to journalArticlepeer-review

198 Scopus citations

Fingerprint

Dive into the research topics of 'Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas'. Together they form a unique fingerprint.

Medicine & Life Sciences